Ministry Health and Family Welfare Current Affairs
The Union Health and Family Welfare Ministry has launched new anti-TB (Tuberculosis) drug Bedaquiline
It was launched by the Union Health Minister J P Nadda as part of the TB national programme
Initially the drug will be made available in six public hospitals in Delhi, Mumbai, Chennai, Guwahati and Ahmedabad. Later it will be introduced in 104 districts across five States.
Bedaquiline is a new anti-TB drug for treatment of Multi-drug-resistant tuberculosis. It specifically targets Mycobacterial ATP synthase, an enzyme which is essential for the supply of energy to Mycobacterium tuberculosis and most other mycobacteria.
- The Union Health Minister also has launched CBNAAT (Cartridge-Based Nucleic Acid Amplification Test) diagnostic machines for the quick diagnosis of TB within two hours.
- These machines have revolutionised rapid molecular test which detects Mycobacterium tuberculosis and rifampicin drug resistance, simultaneously.
- It will help in treating patients of TB patients promptly and can be used in remote and rural areas without sophisticated infrastructure or specialized training.
TB India 2016 Annual Report
- The Union Health Minister also released the TB India 2016 Annual Report and the technical and operational guidelines for TB Control in India 2016.
- The comprehensive sets of guidelines are for management of all forms of TB and strategies for intensified case finding.
- These guidelines adhere of more patient centric approaches and single-window care for patients suffering from HIV and TB.
Union Health and Family Welfare Minister Jagat Prakash Nadda has released the National Framework for Malaria Elimination (NFME) 2016-2030 at New Delhi.
The framework aims to eliminate mosquito borne malaria disease from the country by 2030. This is for the first time government’s health policy has framed intervention have deliverables and time-bound targets.
Under the new framework
- Whole country will be divided into three categories as per malaria prevalence — low (Category 1), moderate (Category 2) and endemic (Category 3) States.
- Objectives: (i) Eliminate malaria from all low and moderate endemic states/UTs by 2022 (ii) Reduce incidence of malaria to less than 1 case per 1000 population in all States/UTs and its elimination by 2024. (iii) Interrupt indigenous transmission of malaria in all category 3 states by 2027. (iv) Prevent re-establishment of malaria local transmission in areas where it has been eliminated and to maintain status of malaria-free in the country by 2030.
- The milestones and targets are set for years 2016, 2020, 2022, 2024, 2027 and 2030 by when the entire country has to sustained zero indigenous cases and deaths due to malaria.
- By the end of 2016 all States/UTs must include malaria elimination in their broader health policies.
- By the end of 2017, all States/UTs are expected to bring down Annual Parasite Incidence [API] to less than one per thousand population.
- By the end of 2020, 15 endemic (category 1) States/UTs are expected to interrupt transmission of malaria and achieve 0 indigenous cases and deaths due to malaria.